Abstract:Objective: To perfect the theory system of minimally invasive treatment for osteonecrosis of the femoral head (ONFH) with β tricalcium phosphate (β-TCP) bioceramic system and evaluate the effectiveness. Methods: Eighteen New Zealand white rabbits aged 7-8 months were used to establish an animal model to verify the vascularization of porous β-TCP bioceramic rods. Micro-CT based three-dimensional reconstruction and fluorescence imaging were used to display the new blood vessels at 4, 8, and 12 weeks after operation. The inserting depth, number and diameter of vessels in the encapsulated area were analyzed. Nine pig femoral specimens were randomly divided into 3 groups ( n=3): group A was normal femur; group B had cavity (core decompression channel+spherical bone defect in femoral head); in group C, mixed bioceramic granules were implanted to fill the defect in femoral head, and porous β-TCP bioceramic rod was implanted into decompression channel. The stiffness and yield load of specimens were analyzed by biomechanical test. A multicenter retrospective study was conducted to analyze 200 patients (232 hips) with femoral head necrosis treated with bioceramic system in 7 hospitals in China between January 2012 and July 2018. There were 145 males and 55 females, with an average age of 42 years (range, 17-76 years). According to the Association Research Circulation Osseous (ARCO) stage, 150 hips were in stage Ⅱ and 82 hips in stage Ⅲ. Postoperative imaging assessment was carried out regularly, and hip function was evaluated by Harris score. The effectiveness of ARCO stage Ⅱ and Ⅲ was also compared. Results: Animal experiments showed that blood vessels could grow into the encapsulated area and penetrate it at 12 weeks. The inserting depth, number and diameter of blood vessels in the encapsulated area gradually increased, and there was significant difference between different time points ( P<0.05). Biomechanical tests showed that the stiffness and yield load of specimens in groups B and C were significantly lower than those in group A, while the yield load in group B were significantly lower than that in group C ( P<0.05). The stiffness in group C was restored to 41.52%±3.96% in group A, and the yield load was restored to 46.14%±7.85%. Clinical study showed that 200 patients were followed up 6-73 months, with an average of 22.7 months. At last follow-up, 12 patients (16 hips) underwent total hip arthroplasty, and the hip survival rate was 93.10%. According to the imaging evaluation, 184 hips (79.31%) were stable and 48 (20.69%) were worse. Harris score (79.3±17.3) was significantly higher than that before operation (57.3±12.0) ( t=18.600, P=0.000). The excellent rate of hip function was 64.22% (149/232). The survival rate of hip joint, imaging score and Harris score of patients in ARCO stage Ⅱ were better than those in ARCO stage Ⅲ ( P<0.05). Conclusion: β-TCP bioceramic system can guide the abundant blood supply of greater trochanter and femoral neck to the femoral head to promote repair; it can partly restore the mechanical properties of the femoral head and neck in the early stage, providing a new minimally invasive hip-preserving method for patients with ONFH, especially for those in early stage.

Short-term efficacy of short stem ceramic-on-ceramic total hip arthroplasty for young and middle-aged patients of femoral head necrosis

Zirconium niobium alloy femoral head in young and middle-aged recent treatment of total hip replacement

Mid-and long-term efficacy of ceramic-on-ceramic total hip arthroplasty in younger patients

[MID- AND LONG-TERM EFFECTIVENESS OF THIRD-GENERATION CERAMIC-ON-CERAMIC TOTAL HIP ARTHROPLASTY IN YOUNGER PATIENTS].

EFFICACY OF CERAMIC ON CERAMIC HIP PROSTHESIS IN YOUNG PATIENTS UNDERGOING TOTAL HIP ARTHROPLASTY

[Minimally invasive treatment for osteonecrosis of the femoral head in ARCO stage Ⅱ and Ⅲ with bioceramic system]

Intermediate outcomes of alumina-on-alumina bearing total hip arthroplastyTotal arthroplasty, replacement, hip; Ceramic; Frictione; Prostheses and implants

Cementless Total Hip Arthroplasty in the Treatment of Patients with Femoral Head Necrosis

Total Hip Arthroplasty with a Cementless Acetabular Component and a Cemented Femoral Component in the Treatment of Chinese Patients with Femoral Head Necrosis

[Resurfacing Arthroplasty for Treatment of Avascular Necrosis of Femoral Head in Young and Middle-Aged Patients].

Mid-term effect of total hip replacement with a tapered femoral component for elderly patients

THE EFFECT OF TWO KINDS OF TOTAL HIP ARTHROPLASTY FOR AVASCULAR NECROSIS OF THE FEMORAL HEAD IN 44 PATIENTS

Primary Total Hip Arthroplasty with Ceramic-On-Ceramic Articulations: Analysis of a Single-Center Series of 1,083 Hips at a Minimum of 10-Year Follow-Up

Use of ceramic-on-ceramic bearing in total hip arthroplasty for posttraumatic arthritis of the hip

Arthroscopy Assisted Lesion Clearance and Bone Graft, Titanium Rod Support Treatment of Early Stage Osteonecrosis of the Femoral Head of the Postoperative Survival Rate Analysis

Retrospective Long-Term Follow-Up Survival Analysis of the Management of Osteonecrosis of the Femoral Head With Pedicled Vascularized Iliac Bone Graft Transfer

SHORT-TERM EFFECTIVENESS OF TOTAL HIP ARTHROPLASTY WITH A TAPERED, MODULAR NECK HIP STEM FOR DEVELOPMENTAL DYSPLASIA OF THE HIP

Ceramic-on-metal coupling in THA: long term clinical and radiographic outcomes using two different short stems

Ceramic-on-ceramic Bearings Total Hip Arthroplasty in Young Patients.

Fourth-generation ceramic-on-ceramic total hip arthroplasty in patients of 55 years or younger: short-term results and complications analysis.

A multi-center retrospective comparative study of third generation Ceramic-on- Ceramic total hip arthroplasty in patients younger than 45 years with or without the sandwich liner: A ten-year minimum